The ARCAD advanced colorectal cancer database—open for business
Open Access
- 21 November 2011
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 23 (1), 281-282
- https://doi.org/10.1093/annonc/mdr547
Abstract
The ARCAD Clinical Trials Program is a worldwide collaboration of clinicians, statisticians and scientists specializing in gastrointestinal malignancies [1]. The collaboration was launched in 2008 through the auspices of a French/USA charitable foundation, ARCAD (Aide et Recherche en Cancérologie Digestive) [2]. The program's objective is to facilitate the development of more efficient clinical trials in gastrointestinal cancers through consensus recommendations and original research.Keywords
This publication has 4 references indexed in Scilit:
- Benefit of Adjuvant Chemotherapy for Resectable Gastric CancerJama-Journal Of The American Medical Association, 2010
- Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials ProgramJournal of Clinical Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT GroupJournal of Clinical Oncology, 2007